Not a good buy right now for an impatient buyer: trend is still bearish and there’s no proprietary “strong buy” signal.
Technicals point to downside continuation risk despite being near short-term oversold levels.
Fundamentals are deteriorating YoY (revenue/EPS down), and there are no near-term news catalysts to change sentiment.
Best case is a short oversold bounce, but risk/reward is not attractive without confirmation (reclaiming key resistance levels).
Technical Analysis
Trend: Bearish structure (SMA_200 > SMA_20 > SMA_5) indicates price is in a downtrend across short/medium/long horizons.
Momentum: MACD histogram at -0.106 and negatively expanding suggests bearish momentum is strengthening, not stabilizing.
RSI: RSI_6 = 30.737 (near oversold boundary). This can support a reflex bounce, but by itself is not a durable buy signal in a confirmed downtrend.
Key levels: Pivot 16.308 is overhead resistance; price (15.43) sits below it.
Near supports: S1 15.628 (already below), then S2 15.208.
Upside resistance: R1 16.988, R2 17.408.
Pattern-based forward odds: Similar-pattern projection shows ~-2.85% over the next month, which reinforces the bearish bias.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Reported put/call ratios are 0.0, which likely reflects missing/illiquid options data rather than a true sentiment read.
Historical volatility is very high (128.35), implying large price swings; without reliable OI/volume context, sentiment inference is weak.
Net takeaway: options market data here does not provide a clear bullish confirmation.
Technical Summary
Sell
10
Buy
6
Positive Catalysts
and price reclaims the 16.31 pivot.
Neutral/Negative Catalysts
Clear bearish technical trend (stacked bearish moving averages + worsening MACD) increases probability that any bounce fails.
No news in the last week: absence of catalysts reduces odds of a sudden positive re-rating.
Forward-looking pattern stats suggest downside over the next month (-2.85%).
Influential/Politician activity: no recent congress trading data available (no visibility into high-profile accumulation).
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: 81.27M, down -16.38% YoY (contraction trend).
Net income: 1.505M, down -12.50% YoY.
EPS: 0.58, down -33.33% YoY (notable earnings power deterioration).
Gross margin: 86.16%, up +0.10% YoY (slight improvement, but not enough to offset revenue/EPS declines).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating changes or price target updates were provided in the data, so a recent Wall Street trend read isn’t available.
Pros (typical bullish case, limited by data): high gross margin profile; potential for operational leverage if growth re-accelerates.
Cons (supported by provided data): declining revenue and EPS YoY; bearish price trend with no confirming catalyst or proprietary buy signal today.
Overall: without visible positive revisions from analysts and with weakening quarter metrics, the “pro” case is currently outmatched by the “con” case.
Wall Street analysts forecast MKTW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MKTW is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast MKTW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MKTW is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 15.160
Low
0
Averages
0
High
0
0
Current: 15.160
Low
0
Averages
0
High
0
UBS
Neutral
maintain
$19 -> $20
AI Analysis
2025-08-14
Reason
UBS
Price Target
$19 -> $20
AI Analysis
2025-08-14
maintain
Neutral
Reason
UBS raised the firm's price target on MarketWise to $20 from $19 and keeps a Neutral rating on the shares.
